JP2002518321A5 - - Google Patents

Download PDF

Info

Publication number
JP2002518321A5
JP2002518321A5 JP2000554356A JP2000554356A JP2002518321A5 JP 2002518321 A5 JP2002518321 A5 JP 2002518321A5 JP 2000554356 A JP2000554356 A JP 2000554356A JP 2000554356 A JP2000554356 A JP 2000554356A JP 2002518321 A5 JP2002518321 A5 JP 2002518321A5
Authority
JP
Japan
Prior art keywords
carrier
vasodilator
healthy humans
atp
enhanced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000554356A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002518321A (ja
Filing date
Publication date
Priority claimed from US09/290,789 external-priority patent/US6159942A/en
Application filed filed Critical
Publication of JP2002518321A publication Critical patent/JP2002518321A/ja
Publication of JP2002518321A5 publication Critical patent/JP2002518321A5/ja
Pending legal-status Critical Current

Links

JP2000554356A 1998-06-19 1999-06-17 エネルギーをインビボで増加させるための組成物 Pending JP2002518321A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US9000198P 1998-06-19 1998-06-19
US60/090,001 1998-06-19
US09/290,789 US6159942A (en) 1998-06-19 1999-04-12 Compositions for increasing energy in vivo
US09/290,789 1999-04-12
PCT/US1999/013720 WO1999065476A2 (en) 1998-06-19 1999-06-17 COMPOSITIONS FOR INCREASING ENERGY $i(IN VIVO)

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2010089732A Division JP2010168394A (ja) 1998-06-19 2010-04-08 エネルギーをインビボで増加させるための組成物
JP2013162441A Division JP2013237697A (ja) 1998-06-19 2013-08-05 エネルギーをインビボで増加させるための組成物

Publications (2)

Publication Number Publication Date
JP2002518321A JP2002518321A (ja) 2002-06-25
JP2002518321A5 true JP2002518321A5 (cg-RX-API-DMAC7.html) 2012-05-17

Family

ID=26781174

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2000554356A Pending JP2002518321A (ja) 1998-06-19 1999-06-17 エネルギーをインビボで増加させるための組成物
JP2010089732A Pending JP2010168394A (ja) 1998-06-19 2010-04-08 エネルギーをインビボで増加させるための組成物
JP2013162441A Pending JP2013237697A (ja) 1998-06-19 2013-08-05 エネルギーをインビボで増加させるための組成物
JP2013229436A Pending JP2014043453A (ja) 1998-06-19 2013-11-05 エネルギーをインビボで増加させるための組成物
JP2016089312A Pending JP2016153421A (ja) 1998-06-19 2016-04-27 エネルギーをインビボで増加させるための組成物

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2010089732A Pending JP2010168394A (ja) 1998-06-19 2010-04-08 エネルギーをインビボで増加させるための組成物
JP2013162441A Pending JP2013237697A (ja) 1998-06-19 2013-08-05 エネルギーをインビボで増加させるための組成物
JP2013229436A Pending JP2014043453A (ja) 1998-06-19 2013-11-05 エネルギーをインビボで増加させるための組成物
JP2016089312A Pending JP2016153421A (ja) 1998-06-19 2016-04-27 エネルギーをインビボで増加させるための組成物

Country Status (10)

Country Link
US (1) US6159942A (cg-RX-API-DMAC7.html)
EP (1) EP1087779B1 (cg-RX-API-DMAC7.html)
JP (5) JP2002518321A (cg-RX-API-DMAC7.html)
CN (1) CN1306431A (cg-RX-API-DMAC7.html)
AT (1) ATE534393T1 (cg-RX-API-DMAC7.html)
AU (1) AU4575299A (cg-RX-API-DMAC7.html)
CA (1) CA2334415C (cg-RX-API-DMAC7.html)
ES (1) ES2374260T3 (cg-RX-API-DMAC7.html)
NZ (1) NZ508478A (cg-RX-API-DMAC7.html)
WO (1) WO1999065476A2 (cg-RX-API-DMAC7.html)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119933A1 (en) * 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
US6339716B1 (en) * 1999-09-24 2002-01-15 Bioenergy Inc. Method for determining viability of a myocardial segment
US6159943A (en) * 1999-09-24 2000-12-12 Bioenergy, Inc. Use of ribose to prevent cramping and soreness in muscles
US6511964B2 (en) 1999-09-24 2003-01-28 Bioenergy, Inc. Method for treating acute mountain sickness
US6703370B1 (en) * 1999-10-27 2004-03-09 Bioenergy, Inc. Use of ribose to treat fibromyalgia
GB2353217B (en) * 1999-10-27 2001-07-18 Bioenergy Inc Use of ribose to treat fibromyalgia
AU1800801A (en) * 1999-11-17 2001-05-30 Eric H. Kuhrts Exercise and muscle enhancement formulations
AU2594001A (en) 1999-12-21 2001-07-03 Bioenergy Inc. Compositions for the storage of platelets
GB2364642B (en) * 2000-01-07 2004-10-27 Bioenergy Inc Compositions for enhancing the immune response
AU2001229672A1 (en) 2000-01-20 2001-07-31 Bioenergy Inc. Use of ribose supplementation for increasing muscle mass and decreasing body fatin humans
US6553254B1 (en) * 2000-04-07 2003-04-22 Keith E. Kenyon Combination of non-living-source physical energy and living-source chemical energy to maximize the salvage of ATP
US6835750B1 (en) 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
IT1317043B1 (it) 2000-06-14 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare potenziante il metabolismo energeticomuscolare, comprendente una alcanoil l-carnitina e ribosio.
JP2004505056A (ja) * 2000-07-28 2004-02-19 バイオエナジー インコーポレイティド 心血管の機能を向上する為の組成物及び方法
US6855727B2 (en) * 2000-12-04 2005-02-15 Yaizu Suisankagaku Industry Co., Ltd. Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect
EP1247525A1 (en) * 2001-04-02 2002-10-09 Bioenergy Inc. Use of a monosaccharide in the manufacture of a medicament against acute mountain sickness
US7629329B2 (en) * 2001-06-04 2009-12-08 Tsi Health Sciences, Inc. Method for increasing muscle mass and strength through administration of adenosine triphosphate
GB2381451A (en) * 2001-11-01 2003-05-07 New Technology Res Ltd Pharmaco-dietary preparation having nutrition-supplementing and nutrition-enhancing effect
DE10215007A1 (de) * 2002-04-05 2003-10-16 Degussa Bioactives Deutschland Verwendung von Kreatinpyruvat zur Steigerung der Ausdauer bei hochintensiven körperlichen Intervallbelastungen
US7547450B2 (en) * 2002-10-24 2009-06-16 Nestec Ltd. Senior feline food
US6838562B2 (en) * 2003-04-01 2005-01-04 Sal Abraham Process for preparing a creatine heterocyclic acid salt and method of use
US7687468B2 (en) * 2003-05-14 2010-03-30 Viacell, LLC. Rejuvenation of stored blood
US8759315B2 (en) * 2003-05-14 2014-06-24 Viacell, Llc Methods for rejuvenating
US20040229205A1 (en) * 2003-05-16 2004-11-18 Ericson Daniel G. Compositions for the storage of platelets
BRPI0506485A (pt) * 2004-01-14 2007-02-13 Bioenergy Inc método para reduzir o tempo de recuperação de um mamìfero submetido a uma anestesia geral, método para aumentar a recuperação de sepsia e uma composição adequada para administração intravenosa
EP1734974A1 (en) * 2004-03-18 2006-12-27 Tanabe Seiyaku Co., Ltd. D-ribose for improving depression-like symptoms
JP2005336176A (ja) * 2004-04-28 2005-12-08 Tanabe Seiyaku Co Ltd 肉体疲労改善剤
US20100099630A1 (en) * 2004-04-29 2010-04-22 Maccarter Dean J Method for improving ventilatory efficiency
WO2005107768A2 (en) 2004-04-29 2005-11-17 Bioenergy, Inc. Method for improving ventilatory efficiency
US7968138B2 (en) * 2004-07-23 2011-06-28 Arnold Nerenberg Food sweetener
US20060029644A1 (en) * 2004-08-06 2006-02-09 Kenyon Keith E In vitro biochemical reactions with free anhydrous D-ribose
WO2007001883A2 (en) * 2005-06-20 2007-01-04 Accera, Inc. Method to reduce oxidative damage and improve mitochondrial efficiency
US7566463B2 (en) 2006-05-03 2009-07-28 C. B. Fleet Company Oral rehydration compositions
US20080146579A1 (en) * 2006-12-15 2008-06-19 N.V. Nutricia Treatment of patients with chronic pulmonary diseases and nutritional compositions therefore
ATE487485T1 (de) * 2007-01-23 2010-11-15 Bioenergy Inc Verwendung von d-ribose zur behandlung von vorhofflimmern
US20090197819A1 (en) * 2007-03-20 2009-08-06 Clarence Albert Johnson Compositions for improving and repairing skin
US20080312169A1 (en) * 2007-03-20 2008-12-18 Clarence Albert Johnson Cosmetic use of D-ribose
CN101356971B (zh) * 2007-07-30 2012-11-07 石药集团中奇制药技术(石家庄)有限公司 一种用于抗疲劳耐缺氧的保健食品组合物
EP2179284B1 (en) 2007-07-31 2016-09-28 Accera, Inc. Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function
US20090061016A1 (en) * 2007-09-05 2009-03-05 Selzer Jonathan A Seawater Based Dietary Supplement Product for Energy and Electrolyte Replacement
US20090232750A1 (en) * 2008-03-13 2009-09-17 St Cyr John A Compositions for indoor tanning
CN102387805A (zh) * 2008-04-02 2012-03-21 生物能公司 核糖在对于急性心肌梗塞的第一反应中的用途
CA2735949C (en) 2008-05-16 2016-04-19 Bioenergy, Inc. Use of ribose in lessening the clinical symptoms of aberrant firing of neurons
US9125881B2 (en) 2008-07-03 2015-09-08 Accera, Inc. Monoglyceride of acetoacetate and derivatives for the treatment of neurological disorders
JP2012500261A (ja) * 2008-08-20 2012-01-05 バイオエナジー インコーポレイティド 疲労した対象のためのd−リボースの使用
IT1391588B1 (it) * 2008-10-15 2012-01-11 Giellepi Chemicals S P A Composizione sinergica per il recupero e la riduzione del danno ischemico lieve
US8255453B2 (en) 2009-09-14 2012-08-28 International Business Machines Corporation Public BOT management in private networks
WO2011075185A1 (en) 2009-12-18 2011-06-23 Oligasis Targeted drug phosphorylcholine polymer conjugates
CA2789709C (en) 2010-02-16 2018-03-20 Viacell, Llc Arginine-containing compositions and methods for treating red blood cells
US20110229871A1 (en) 2010-02-16 2011-09-22 Ericson Daniel G Nucleoside-containing compositions and methods for treating red blood cells
CN102058045B (zh) * 2010-10-26 2012-09-19 开平牵牛生化制药有限公司 一种用于补充人体能量和恢复疲劳的饮品
ES2819217T3 (es) 2013-09-08 2021-04-15 Kodiak Sciences Inc Conjugados de polímeros iónicos dipolares y factor VIII
BR112016028654A2 (pt) 2014-06-12 2018-07-10 Lonza Ag método para diminuição de dano muscular esquelético e / ou estresse oxidativo em mamíferos
JP2017537079A (ja) * 2014-11-03 2017-12-14 バイオエナジー ライフ サイエンス,インコーポレイティド 身体的ストレスへの適応を強化するためのd−リボースの使用
US10888571B2 (en) 2015-12-18 2021-01-12 Lonza Consumer Health Inc. Method and composition for increasing muscle protein synthesis and/or functional strength in mammals
EP3411041A1 (en) 2016-02-01 2018-12-12 RiboCor, Inc. Use of ribose for treatment of subjects having congestive heart failure
CN108433106A (zh) * 2017-11-07 2018-08-24 付少才 一种耐缺氧活性果糖粉(液)组合物
CA3157509A1 (en) 2019-10-10 2021-04-15 Kodiak Sciences Inc. Methods of treating an eye disorder
JPWO2023135827A1 (cg-RX-API-DMAC7.html) * 2022-01-13 2023-07-20

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6049764A (ja) * 1983-08-29 1985-03-19 Ajinomoto Co Inc 食品組成物
JPS6094075A (ja) * 1983-10-31 1985-05-27 Ajinomoto Co Inc 果汁飲料組成物
US4605644A (en) * 1985-02-07 1986-08-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia employing ribose and adenine
US4719201A (en) * 1985-02-07 1988-01-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia
US4824660A (en) * 1985-06-06 1989-04-25 Paul S. Angello Method of determining the viability of tissue in an organism
JPS6232860A (ja) * 1985-08-06 1987-02-12 Riichiro Yamazaki 健康食品
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
AU2228888A (en) * 1987-10-14 1989-05-25 Takeda Chemical Industries Ltd. Aqueous pharmaceutical preparation for oral administration
JPH02212A (ja) * 1987-10-14 1990-01-05 Takeda Chem Ind Ltd 経口用水性製剤
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
US4981687A (en) * 1988-07-29 1991-01-01 University Of Florida Compositions and methods for achieving improved physiological response to exercise
US4968719A (en) * 1989-04-03 1990-11-06 Sigma Tau, Industrie Farmaceutiche Riunite Spa Method for treating vascular disease
US5114723A (en) * 1990-02-27 1992-05-19 University Of Texas System Board Of Regents Beverage compositions for human consumption
FR2668039B1 (fr) * 1990-10-18 1993-06-25 Pernod Ricard Boisson dietetique destinee a permettre de soutenir l'effort.
IT1247125B (it) * 1991-03-01 1994-12-12 Depha Team Srl Composizioni dietetiche o farmaceutiche per il ripristino del contenuto cellulare degli adenin nucleotidi nel muscolo scheletrico e cardiaco.
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
GB9215746D0 (en) * 1992-07-24 1992-09-09 Hultman Eric A method of increasing creatine supply depot
DE4228215A1 (de) * 1992-08-25 1994-03-03 Pliml Wolfgang Verwendung von Ribose zur Herstellung eines Arzneimittels zur Behandlung von Leistungsschwächen des Körpers, insbesondere von Organinsuffizienzen
US5852058A (en) * 1993-06-11 1998-12-22 The Board Of Trustees Of The Leland Stanford Junior University Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
JPH07233070A (ja) * 1994-02-23 1995-09-05 Taisho Pharmaceut Co Ltd 疲労改善剤
JP3213666B2 (ja) * 1994-02-28 2001-10-02 治彦 末岡 クレアチン飲料の製造方法
AU1780395A (en) * 1994-05-02 1995-11-09 Omeara (Proprietary) Limited Amino acid, carnitine and magnesium supplementation
US5536751A (en) * 1994-05-09 1996-07-16 The United States Of America As Represented By The Secretary Of The Army Pharmaceutical alpha-keto carboxylic acid compositions method of making and use thereof
JPH07330584A (ja) * 1994-06-08 1995-12-19 Taisho Pharmaceut Co Ltd 疲労改善剤
GB9517443D0 (en) * 1994-12-17 1995-10-25 Univ Nottingham Increasing creatine and glycogen concentration in muscle
JP3595373B2 (ja) * 1995-02-20 2004-12-02 治彦 末岡 クレアチン飲料
US5707971A (en) * 1995-06-07 1998-01-13 Life Resuscitation Technologies, Inc. Modulation of glycolytic ATP production
US5709971A (en) 1995-06-20 1998-01-20 Eastman Kodak Company Dye imbibition printing blanks with antistatic layer
GB9611356D0 (en) * 1996-05-31 1996-08-07 Howard Alan N Improvements in or relating to compositions containing Creatine, and other ergogenic compounds
JP3563892B2 (ja) * 1996-10-08 2004-09-08 伊藤ハム株式会社 体力増強・疲労回復剤及びそれを用いた食品
DE19650755A1 (de) * 1996-12-06 1998-06-10 Wolfgang Dr Pliml Anwendung von Ribose zur Leistungssteigerung
GB9715340D0 (en) * 1997-07-22 1997-09-24 Cerestar Holding Bv Beverages for enhanced physical performance

Similar Documents

Publication Publication Date Title
US6159942A (en) Compositions for increasing energy in vivo
KR970000575B1 (ko) 운동에 대한 생리적 반응을 개선시키기 위한 조성물 및 그 방법
ES2240163T3 (es) Utilizaciones terapeuticas de polimeros y de oligomeros a base de gamma-hidroxibutirano (ghb).
US6534480B2 (en) Compositions for increasing energy in vivo
JP2003517437A5 (ja) 処方した人の脳シチジンレベルを上昇させる薬を調合するためのウリジンの使用方法及び同薬として使用する組成物
JP4945710B2 (ja) 筋肉の痙攣及び筋肉痛を予防するためのリボースの利用
EP1210940A2 (en) Antifatigue composition
EP1268504A1 (en) Nucleoside compounds and uses thereof
JP2013166789A (ja) 骨関節炎の治療におけるa3アデノシン受容体アゴニストの使用
CA2202397C (en) Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders
CN1299690C (zh) 用于提高心血管功能的组合物
ES2271042T3 (es) Suplemento alimenticio con un efecto adelgazante.
JP2002515892A (ja) サイトカインが関係する疾患治療法
Simpson et al. Adenosine in exercise adaptation.
AU651824B2 (en) Pharmaceutical composition
EP1745789A1 (en) Compositions comprising ribose for increasing energy in vivo
CN110327362A (zh) 次黄嘌呤核苷酸在制备抗抑郁药物中的应用
CN1365279A (zh) 用于降低身体运动期间耗氧量的制剂
KR100523354B1 (ko) 지구성 운동시 피로억제 및 운동 수행 후 면역기능 향상을위한 약학적 조성물 또는 기능성 식품
EP1277759A1 (en) Cytokine related treatments of disease
HK1052937A1 (en) Cytokine related treatments of disease
CZ246999A3 (cs) Způsob snižující podávanou dávku prvého léku v léčení choroby
RU2002125633A (ru) Композиция и способ лечения инсулиновой резистентности и сахарного диабета